PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.

Saved in:
Bibliographic Details
Title: PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.
Authors: Zhang H; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.; Department of Colorectal Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Li C; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China., Liao S; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China., Tu Y; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China., Sun S; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China., Yao F; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China., Li Z; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China., Wang Z; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
Source: Cancer biology & therapy [Cancer Biol Ther] 2022 Dec 31; Vol. 23 (1), pp. 1-11.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1555-8576
DOI:10.1080/15384047.2022.2125260